1206123-55-8

Basic information

• Product Name: 2-(7-(4-cyclopentyl-3-(trifluoromethyl)benzyloxy)-1,2,3,4-tetrahydrocyclopenta[b]indol-3-yl)acetic acid
• Synonyms: 2-(7-(4-cyclopentyl-3-(trifluoromethyl)benzyloxy)-1,2,3,4-tetrahydrocyclopenta[b]indol-3-yl)acetic acid
• CAS NO: 1206123-55-8
• Molecular Weight: 457.493
• Mol File: 1206123-55-8.mol
• Article Data: 2

Chemical Properties

• CAS DataBase Reference: 2-(7-(4-cyclopentyl-3-(trifluoromethyl)benzyloxy)-1,2,3,4-tetrahydrocyclopenta[b]indol-3-yl)acetic acid(CAS DataBase Reference)
• NIST Chemistry Reference: 2-(7-(4-cyclopentyl-3-(trifluoromethyl)benzyloxy)-1,2,3,4-tetrahydrocyclopenta[b]indol-3-yl)acetic acid(1206123-55-8)
• EPA Substance Registry System: 2-(7-(4-cyclopentyl-3-(trifluoromethyl)benzyloxy)-1,2,3,4-tetrahydrocyclopenta[b]indol-3-yl)acetic acid(1206123-55-8)

Safety Data

• Hazardous Substances Data: 1206123-55-8(Hazardous Substances Data)

Upstream product

• 1206124-14-2 ethyl 2-(7-methoxy-1,2,3,4-tetrahydrocyclopenta[b]indol-3-yl)acetate 
• 20826-94-2 ethyl (2-oxocyclopentyl)acetate 
• 957208-65-0 4-(chloromethyl)-1-cyclopentyl-2-(trifluoromethyl)benzene 
• 191348-14-8 2-iodo-4-methoxylaniline 
• 957205-39-9 (4-cyclopentyl-3-(trifluoromethyl)phenyl)methanol 
• 161622-16-8 methyl 4-cyclopentyl-3-(trifluoromethyl)benzoate 
• 115591-64-5 4-chloro-3-trifluoromethylbenzoic acid methyl ester 
• 1737-36-6 4-chloro-3-(trifluoromethyl)benzoic acid 
• 1206124-34-6 (R/S)-ethyl 2-(7-(4-cyclopentyl-3-(trifluoromethyl)benzyloxy)-1,2,3,4-tetrahydrocyclopenta[b]indol-3-yl)acetate 

Downstream Products

• 1206123-51-4 (S)-2-(7-(4-cyclopentyl-3-(trifluoromethyl)benzyloxy)-1,2,3,4-tetrahydrocyclopenta[b]indol-3-yl)acetic acid 
• 1206123-37-6 [(3R)-7-{[4-cyclopentyl-3-(trifluoromethyl)phenyl]methoxy}-1,2,3,4-tetrahydrocyclopenta[b]indol-3-yl]acetic acid 

Relevant articles and documents

Discovery of APD334: Design of a clinical stage functional antagonist of the sphingosine-1-phosphate-1 receptor

APD334 was discovered as part of our internal effort to identify potent, centrally available, functional antagonists of the S1P1 receptor for use as next generation therapeutics for treating multiple sclerosis (MS) and other autoimmune diseases